Company: KPEA
Filing Date: 2025-01-14
Form Type: 10-K
Source: 0001493152-25-002124
Chunk: 664

Company: Kun Peng International Ltd.
Filing Date: 2025-01-14
Form: 10-K
Item: Item 1A
Chunk 664
---
 actions to eliminate perceived unfair competitive advantages created by alleged manipulating actions.
Changes to national trade or investment policies, treaties and tariffs, fluctuations in exchange rates, or the perception that these
changes could occur could adversely affect the financial and economic conditions in China, as well as our future international and cross-border
operations, our financial condition, and our results of operations.

Our
business is dependent on King Eagle VIE and operations in China, and marketing and selling health-related products, and any inability
to obtain products or market and sell such products could have a material adverse effect on our business, operating results and financial
condition.

We
focus on health-related products and services. Kun Zhi Jian and Kun Zhi Jian Mini Program are designed to enable health-related products to be sold by us and by
third parties. Substantially all of our current and future operations are expected to be located in China.. This concentration exposes
us to risks associated with doing business globally. The political, legal and cultural environment in China is rapidly evolving, and
any change that impairs our ability to obtain products from manufacturers in that region, or to obtain products at marketable rates,
could have a material adverse effect on our business, operating results and financial condition.

There
are quotas and trade restrictions on certain categories of goods and apparel from China and countries that are not subject to the World
Trade Organization Agreement, which could have a significant impact on our sourcing patterns in the future. In addition, political uncertainty,
including the election of President Trump, in the United States may result in significant changes to U.S. trade policies, treaties and
tariffs, potentially involving trade policies and tariffs regarding China, including the potential disallowance of tax deductions for
imported merchandise or the imposition of unilateral tariffs on imported products.

These
developments, or the perception that any of them could occur, may have a material adverse effect on global economic conditions and the
stability of global financial markets, and may significantly reduce global trade and, in particular, trade between these nations and
the United States. Any of these factors could depress economic activity, restrict our sourcing from suppliers and have a material adverse
effect on our business, financial condition and results of operations and affect our strategy in Asia and elsewhere around the world.
We cannot predict whether any of our health related products will be subject to additional trade restrictions imposed by the United States
and foreign governments, nor can we predict the likelihood, type or effect of any such restrictions. Future trade restrictions, including
increased